Menu
  • Home
  • Technologies
    • CAR T-cells
    • CRISPR-Cas9
    • Custom Cell Lines
    • Optogenetics
    • RNA Interference
    • Transgenesis
  • Lentiviral Vectors
    • Products
      • Vectors
      • Extra QC
    • CAR T-cells
    • Live-tracking
    • Protocols
    • FAQ
  • About Us
    • About Us
    • References
    • News
    • Blog
    • Contact

Blog

  • Home
  • Blog

Recent News about GEG Tech

  • Universal CAR T cell therapy helps beat a hard-to-treat pediatric cancer

    Universal CAR T cell therapy helps beat a hard-to-treat pediatric cancer

    February 23, 2021
  • Modified version of CAR T-cell therapy shows promise in targeting neuroblastoma

    Modified version of CAR T-cell therapy shows promise in targeting neuroblastoma

    February 8, 2021
  • Penn study opens the door to let CAR T cells reach the tumor microenvironment

    Penn study opens the door to let CAR T cells reach the tumor microenvironment

    January 28, 2021
  • GEG-tech signs Distribution Agreement with tebu-bio

    GEG-tech signs Distribution Agreement with tebu-bio

    March 2, 2020
  • Innovation in cancerology: meeting in Monaco

    Innovation in cancerology: meeting in Monaco

    January 28, 2020

Expression system for purification of secreted proteins

Lentiviral expression system for the purification of secreted proteins from human cell cultures Recombinant proteins of therapeutic use are ideally produced in human cells to ensure appropriate co- and post-translational modifications. CHO cells are mostly used but recent studies highlight that proteins produced in this cell line have a different…

  • September 20, 2016
  • Bioproduction

Novel vesiculovirus envelope glycoproteins

Pseudotyping of lentiviral vector with novel vesiculovirus envelope glycoproteins derived from Chandipura and Piry viruses Lentiviral vectors are commonly pseudotyped with the heterologous envelope VSV-G due to its broad host tropism and stability conferred. However, in some cases, the sensibility of VSV-G by human complement hinders the use of lentiviral…

  • August 23, 2016
  • Vectorology

The rise of CAR-T therapies

Lentiviral vectors: the secret behind the rise of CAR-T therapies CAR-T has become a hype within the biotech field recently. Companies promising to deliver this new generation of therapies are shining on stock markets, sometimes leading to billion-dollar valuations. But the rise of CAR-Ts would not have been possible without…

  • August 23, 2016
  • Cancer immunotherapy

Strain-promoted click reaction

Surface modification via strain-promoted click reaction facilitates targeted lentiviral transduction Since the last decade, the Lentiviral Vector has emerged as a promising vector for gene delivery. This is coming from its high efficiency to transduce a large variety of cells in vitro as well as in vivo. Moreover, the Lentiviral Vector has a…

  • July 19, 2016
  • Vectorology

Lentiviral vector transduction in human CD34+ cells

Kinetics of lentiviral vector transduction in human CD34+ cells Human hematopoietic stem cells (HSCs) are refractory to the lentiviral vector transduction. Improvement of transduction efficiency for human HSCs remains crucial for further development of gene therapy especially for non-immunodeficiency diseases. In this report, the authors investigated which step(s) could be…

  • June 22, 2016
  • Cancer immunotherapy

3rd Generation Cocal Envelope Producer Cell Lines

Development of 3rd Generation Cocal Envelope Producer Cell Lines for Robust Lentiviral Gene Transfer into Hematopoietic Stem Cells and T Cells Lentiviral vectors (LVs) are currently considered the gold standard for hematopoietic stem cell (HSC) gene therapy and for immunotherapies with genetically modified T cells. LVs have commonly been pseudotyped…

  • May 30, 2016
  • Vectorology

Safer gene editing

Lentivirus pre-packed with Cas9 protein for safer gene editing The CRISPR/Cas9 system has democratized genome editing and opens the door to an unprecedented use of genome editors. This powerful method is allowing researchers to ask questions that were previously unaskable, leading to new insights into the basis of fundamental biological…

  • April 14, 2016
  • Gene editing

RNA delivery

Highly efficient in vitro and in vivo delivery of functional RNAs using new versatile MS2-chimeric retrovirus-like particles RNA delivery is an attractive strategy to achieve transient gene expression in research projects and in cell- or gene-based therapies. However, RNA transfer tools developed until that are not enough efficient to be…

  • April 8, 2016
  • Vectorology

DECKO

DECKO: Single-oligo, dual-CRISPR deletion of genomic elements including long non-coding RNAs Recently, Estel Aparicio-Prat et al. published a study about a new genome editing system based on CRISPR and lentiviral vector technologies, this tool was specifically designed to knockout long non-coding RNAs. They spell this new system DECKO for Double…

  • April 8, 2016
  • Gene editing
  • ←
  • 1
  • 2
  • 3

Lentiviral Vectors

Lenti-One

Extra QC

Live-Tracking

Protocols

FAQ

Services

RNA Interference

Transgenesis

CAR T-Cells

Optogenetics

Company

About Us

References

News

Contact

Terms and Conditions

Privacy & Cookies Policy

Social

Site Map

Site Map

© 2019 GEG Tech, All Rights Reserved - Optimized by Atrium Labs. On Wise Cloud Managed Hosting

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish.Accept Reject Read More
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled

Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.

Non-necessary

Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.

SAVE & ACCEPT